Companies / BOC Sciences / Recaticimab
BOC Sciences

Recaticimab | BOC Sciences

Recaticimab is a humanized monoclonal antibody directed against PCSK9. Recaticimab could be used as an add-on to moderate-intensity statin therapy significantly and substantially reduced the LDL-C level. Recaticimab has the potential for the treatment of uncontrolled hypercholesterolaemia.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.